Keynote 775

Trial description
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with Advanced Endometrial Cancer
Contact name
Dr Christine Parkinson
Trial start date
Wednesday, October 17, 2018
Trial end date
Saturday, October 17, 2020
Trial tumour type
Show on Radiotherapy